The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Kim I.A.
National Medical Research Center for Otorhinolaryngology;
N.I. Pirogov Russian National Research Medical University
Trukhin D.V.
National Medical Research Center for Otorhinolaryngology;
N.I. Pirogov Russian National Research Medical University
Sukhostavtseva T.V.
National Medical Research Center for Otorhinolaryngology;
N.I. Pirogov Russian National Research Medical University
Possibilities of using bacterial lysates in the treatment and prevention of upper respiratory tract infectious diseases
Journal: Russian Rhinology. 2024;32(4): 314‑322
Views: 165
Downloaded: 1
To cite this article:
Kim IA, Trukhin DV, Sukhostavtseva TV. Possibilities of using bacterial lysates in the treatment and prevention of upper respiratory tract infectious diseases. Russian Rhinology.
2024;32(4):314‑322. (In Russ.)
https://doi.org/10.17116/rosrino202432041314
The significant prevalence of respiratory diseases and the high frequency of antibiotic prescriptions for these patients highlight the relevance of new approaches in treating and preventing upper respiratory tract (URT) infections. One such direction is immunocorrective therapy using microbial-origin preparations (bacterial lysates), which stimulate the immune system and have dual action (specific — «vaccinating» and non-specific — immunostimulating), accompanied by the formation of local protective reactions in the mucous membrane of the URT.
Analysis and summary of published data on the significance of topical bacterial lysates in contemporary treatment and prevention algorithms for acute and chronic upper respiratory tract infections.
We analyzed publications indexed in Medline, Embase, and PubMed databases. The materials were selected using keywords such as UTR infections, immunotherapy, immunoprophylaxis, topical bacterial lysates, and Imudon.
Topical bacterial lysates, which are preparations consisting of a mixture of antigens from inactivated bacteria — the most common causative agents of infectious diseases — act directly at the site of inflammation without negatively impacting the human microbiome. They have a high safety profile, combine well with other medications, and can be used in patients of various ages. Using the topical immunomodulator Imudon in patients with URT infections helps reduce the frequency of acute episodes and exacerbations of chronic respiratory diseases, significantly decrease their duration, lessen the severity, and prevent the development of complications. In addition to its high efficacy, Imudon preparation has been well tolerated.
Topical immunotherapy has a distinct preventive effect, helping to avert potential complications and improving the quality of life for patients. This allows for the inclusion of the topical immunomodulator Imudon in the comprehensive treatment of acute infections and the prevention of recurrent URT infections.
Keywords:
Authors:
Kim I.A.
National Medical Research Center for Otorhinolaryngology;
N.I. Pirogov Russian National Research Medical University
Trukhin D.V.
National Medical Research Center for Otorhinolaryngology;
N.I. Pirogov Russian National Research Medical University
Sukhostavtseva T.V.
National Medical Research Center for Otorhinolaryngology;
N.I. Pirogov Russian National Research Medical University
Received:
08.10.2024
Accepted:
17.10.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.